Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n...
Transcript of Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n...
![Page 1: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/1.jpg)
+
Shake It Up: Seizure Prophylaxis and Status Epilepticus Management
Emily Yarborough, PharmD PGY2 Critical Care Pharmacy Resident January 4, 2018
![Page 2: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/2.jpg)
+
Patient Case 1
![Page 3: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/3.jpg)
+Patient Case 1 n JM is a 68 yo M involved in serious MVC
n PMH: HTN, hyperlipidemia, T2DM, atrial fibrillation
n Home Medications: Aspirin 81 mg PO daily, atorvastatin 40 mg PO daily, lisinopril 20 mg PO daily, warfarin 5 mg PO daily
n Physical Exam: Intubated, 5 cm laceration across the forehead, displaced shoulder
n Head CT: R frontal region skull fracture, small R frontal lobe contusion
125 102 20
3.8 28 1.2 225
![Page 4: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/4.jpg)
+
Traumatic Brain Injury (TBI) Seizure Prophylaxis
![Page 5: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/5.jpg)
+TBI Related Seizures
n Seizure onset n Early 0 - 7 days n Late > 7 days
n Risk factors for seizure development n Alcoholism
n Intracranial hemorrhage n Loss of consciousness n Penetrating injuries
n Severity of injury n Lesion location
Carney N, Totten AM, Oʼreilly C, et al. Neurosurgery. 2017 Jan 1;80(1):6-15.
![Page 6: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/6.jpg)
+TBI Seizure Prophylaxis
Carney N, Totten AM, Oʼreilly C, et al. Neurosurgery. 2017 Jan 1;80(1):6-15.
Early Seizures • Phenytoin preferred • Levetiracetam as
alternative
Late Seizures • Antiepileptic
prophylaxis not recommended
Mild - Moderate TBI • Lower rates of seizures • Phenytoin appropriate
![Page 7: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/7.jpg)
+Early vs Late Seizure Prophylaxis
Temkin NR, Dikmen SS, et al. N Engl J Med. 1990;323(8):497-502.
p<0.001 p>0.2
![Page 8: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/8.jpg)
+Phenytoin
Pharmacological class Hydantoin anticonvulsant
Mechanism Increases efflux or decreases influx of sodium ions across cell membranes
Loading dose 15 - 20 mg/kg IV over 30 – 60 minutes 300 mg PO q6h for 3 doses (900 mg total)
Maintenance dose 5 mg/kg/day IV or PO divided in 1 to 3 doses or 300-400 mg/day in divided doses
Serum levels 10 – 20 mg/L
Drug-drug interactions Amiodarone, warfarin, digoxin, birth control, H2RAs, antidepressants
Adverse effects Confusion, drowsiness, bradycardia, ataxia, hypotension Serious: Stevens-Johnson syndrome, arrhythmias, CNS depression, purple glove syndrome
Phenytoin. [package insert]. Pfizer. New York, NY. 2011.
![Page 9: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/9.jpg)
+Levetiracetam
Pharmacological class Hydantoin anticonvulsant
Mechanism Increases efflux or decreases influx of sodium ions across cell membranes Prolongs effective refractory period
Dose 1000 mg IV every 12 hours Needs renal dose adjustment
Serum levels Not required
Drug-drug interactions Opioids, SSRIs
Adverse effects Vomiting, increased intracranial pressure, behavioral problems (anxiety, aggression), hypertension, anemia, abnormal AST/ALT
Keppra. [package insert]. UCB. Smyrna, GA. 1999.
![Page 10: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/10.jpg)
+Phenytoin vs Levetiracetam
Title Population Intervention Results
Inaba et al 2013
Severe blunt TBI • LEV 1g IV q12h • PHT 20 mg/kg IV load
followed by maintenance 5 mg/kg/day divided TID
• N=813 • No significant differences in
seizure rates (1.5% vs 1.5%, p=0.997)
• More treatment discontinuation with phenytoin due to ADRs (0% vs 2.9%, p< 0.001)
KE Jones et al 2008
Severe TBI • LEV or PHT monotherapy
• 32 LEV, 41 PHT • LEV and PHT had equivalent
incidence of seizure activity (p=0.556)
• Higher incidence of abnormal EEG findings with LEV (p=0.003)
Szaflarski et al 2010
Severe TBI or subarachnoid hemorrhage
• LEV 20 mg/kg IV load, maintenance of 1g IV q12h
• Fosphenytoin 20 mg/kg IV load, maintenance PHT 5 mg/kg/day divided BID
• 52 patients (34 LEV, 18 PHT) • LEV patients experienced
better long term outcomes than those on PHT; lower disability rating scale score at 3 months (p=0.042); higher GCS at 6 months (p=0.039)
Inaba K, Menaker J, Branco BC, et al. J Trauma Acute Care Surg. 2013;74(3):766-71. Jones KE, Puccio AM, Harshman KJ, et al. Neurosurg Focus. 2008;25(4):E3.
Szaflarski JP, Sangha KS, Lindsell CJ, et al. Neurocrit Care. 2010;12(2):165-72.
![Page 11: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/11.jpg)
+Other Pharmacological Agents
n Potential role n Carbamazepine
n Avoid n Valproate n Phenobarbital
Carney N, Totten AM, Oʼreilly C, et al. Neurosurgery. 2017 Jan 1;80(1):6-15. Dikmen SS, Machamer JE, Winn HR, et al. Neurology. 2000;54(4):895-902.
Torbic H, Forni AA, et al. Am J Health Syst Pharm. 2013;70(9):759-66.
![Page 12: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/12.jpg)
+Valproate Results: Late Seizures
p=0.19
Temkin NR, Dikmen SS, Anderson GD, et al. J Neurosurg. 1999;91(4):593-600.
![Page 13: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/13.jpg)
+Valproate Results: Mortality
Temkin NR, Dikmen SS, Anderson GD, et al. J Neurosurg. 1999;91(4):593-600.
p=0.07
![Page 14: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/14.jpg)
+Phenobarbital Primary Literature Cooperative Prospective Study on Posttraumatic Epilepsy: Risk Factors and the Effect of Prophylactic Anticonvulsant
Comparison • Group I- Severe head injury • A-phenobarbital • B- control
• Group II- Mild head injury
Primary outcome • Incidence of epilepsy
Secondary outcomes • Factors influencing posttraumatic epilepsy
Results • N=191 (50 phenobarbital, 76 placebo, 65 mild injury)
• Epileptic attacks occurred in 15 cases (12.7% of group I), consisting of 8 (16.0%) in group IA, 8 in group IB (10.5%) and 0 in group II
• Risk factors associated with epilepsy: disturbance of consciousness, neurological sign, abnormal CT findings
Manaka S. Jpn J Psychiatry Neurol. 1992;46(2):311-5.
![Page 15: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/15.jpg)
+Phenobarbital Results
Manaka S. Jpn J Psychiatry Neurol. 1992;46(2):311-5.
![Page 16: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/16.jpg)
+
Patient Case 2
![Page 17: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/17.jpg)
+Patient Case 2
n AW is a 21 yo M who presents with complaint of severe headache. He was found in a gym bathroom with L sided weakness and urinary incontinence after lifting weights. In the ED he follows commands but does have L hemiparesis.
n PMH: Asthma, ADHD
n Home Medications: Albuterol inhaler, lisdexamphetamine 30 mg PO QAM
n Imaging: Emergent non contrast head CT reveals R frontal intracerebral hemorrhage (ICH)
Accessed at: https://www.thoracic.org. November 27, 2017.
136 100 24
3.8 23 1.5 117
![Page 18: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/18.jpg)
+
ICH Seizure Prophylaxis
![Page 19: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/19.jpg)
+ICH Guidelines
n Clinical seizures should be treated with antiseizure drugs
n Patients with a change in mental status, electrographic seizures on EEG should be treated
n Continuous EEG monitoring is indicated in ICH patients with depressed mental status
n Prophylactic antiseizure medication is not recommended
Hemphill JC, Greenberg SM, Anderson CS, et al. Stroke. 2015;46(7):2032-60.
![Page 20: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/20.jpg)
+ICH Primary Literature
Naidech AM, Garg RK, Liebling S, et al. Stroke. 2009;40(12):3810-5.
• Phenytoin was associated with: • Increased fever (p=0.03) • Worse NIHSS at 14 days
(p=0.003) • Worse modified Rankin
scale at 14 days, 28 days, and 3 months
![Page 21: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/21.jpg)
+ICH Primary Literature
Title Population Intervention Results Messé et al 2009
Primary ICH PHT, VPA, or lamotrigine within 6h of symptom onset compared to placebo
• N=295 • Initiation of AEDs was
associated with poor outcome (OR 6.8; 95% CI 2.2-21.2, p=0.001)
Gilad et al 2011
Non-traumatic, non-aneurysmatic spontaneous ICH
VPA or placebo for 1 month
• N=72 (36 VPA, 36 placebo) • 21% of patients developed
seizures with a by-treatment difference in incident seizures not detected (p=0.5) but a reduction in early seizures was observed with VPA
. Messé SR, Sansing LH, Cucchiara BL, et al. Neurocrit Care. 2009;11(1):38-44.
Gilad R, Boaz M, Dabby R, Sadeh M, Lampl Y. Epilepsy Res. 2011;95(3):227-31.
![Page 22: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/22.jpg)
+
Patient Case 3
![Page 23: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/23.jpg)
+Patient Case 3
n CM is a 48 yo F who presents with loss of consciousness followed by a severe headache after regaining consciousness.
n PMH: T2DM, HTN, osteoarthritis
n Physical exam: R gaze preference, diaphoretic, GCS 15, L facial droop
n Imaging: CT head shows extensive subarachnoid hemorrhage (SAH)
Home Medications
Metformin 500 mg PO BID
Amlodipine 10 mg PO daily
Accessed at: https://medium.com/@DrJavahery/case-study-series-subarachnoid-hemorrhage-sah-ce0ef1bf59d0. November 24, 2017.
![Page 24: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/24.jpg)
+
SAH Seizure Prophylaxis
![Page 25: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/25.jpg)
+SAH Guidelines
n The use of prophylactic anticonvulsants may be considered
n Routine long-term use of anticonvulsants is not recommended but may be considered
n Prior seizure
n Intracerebral hematoma
n Intractable hypertension
n Infarction or aneurysm at the middle cerebral artery
Connolly ES, Rabinstein AA, Carhuapoma JR, et al. Stroke. 2012;43(6):1711-37.
![Page 26: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/26.jpg)
+SAH Seizure Prophylaxis
Prophylactic Antiepileptics and Seizure Incidence Following Subarachnoid Hemorrhage
Design • Retrospective propensity score-matched analysis
Comparison • Patients receiving antiepileptics versus those not
Primary outcome • Seizure occurrence diagnosed clinically and with EEG
Secondary outcomes
• Timing, type of seizure activity, incidence of delayed ischemic neurologic deficits, 12-month functional outcome on modified Rankin Score
Results • 353 patients • Overall, the incidence of seizures did not vary
significantly based on the use of prophylactic antiepileptics (11% vs 8%, p=0.33)
Panczykowski D, Pease M, Zhao Y, et al. Stroke. 2016;47(7):1754-60.
![Page 27: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/27.jpg)
+ SAH Seizure Prophylaxis with PHT Associated with Worse Outcomes
Naidech AM, Kreiter KT, Janjua N, et al. Stroke. 2005;36(3):583-7. TICS: telephone interview for cognitive status
![Page 28: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/28.jpg)
+SAH Seizure Prophylaxis
Title Population Intervention Results Rosengart et al 2007
Aneurysmal SAH from four randomized, double-blind placebo-controlled trials
AED (phenytoin, phenobarbital, carbamazepine)
• N=3552 • Patients treated with AEDs
had worse outcomes based on GCS
• Increased odds • Cerebral vasospasm • Neurological
deterioration • Cerebral infarction • Elevated temperature
Rosengart AJ, Huo JD, Tolentino J, et al. J Neurosurg. 2007;107(2):253-60.
![Page 29: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/29.jpg)
+SAH Seizure Prophylaxis: Who?
- Intracerebral hemorrhage
- Middle cerebral and anterior communicating artery aneurysms
- Increased thickness of SAH clot
- Rebleeding
- Infarction
- Poor neurological grade
Incr
ease
d r
isk
Connolly ES, Rabinstein AA, Carhuapoma JR, et al. Stroke. 2012;43(6):1711-37.
![Page 30: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/30.jpg)
+
Patient Case 4
![Page 31: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/31.jpg)
+Patient Case 4
n PK is a 69 yo F referred to CRMH with progressive headache, nausea and vomiting for the past 3 days
n PMH: NSTEMI, CVA, HTN
n Imaging: Brain CT reveals L temporal subdural hematoma (SDH) with slight mass effect
Chye CL, Lin KH, Ou CH, Sun CK, Chang IW, Liang CL. BMC Surg. 2015;15:60.
Home Medications
Aspirin 81 mg PO daily
Atorvastatin 80 mg PO daily
Lisinopril 20 mg PO daily
Metoprolol tartrate 50 mg PO BID
![Page 32: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/32.jpg)
+SDH Guidelines
n Use of seizure prophylaxis recommended for 7 days
n Increased risk for seizures n Isolated acute SDH
n Evacuation by craniotomy n Worse GCS before and after surgery
n Agents n Phenytoin preferred n Levetiracetam as an alternative
Gerard C, Busl KM. Neurol. 2014;16(1):275.
![Page 33: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/33.jpg)
+SDH: Primary Literature Title Population Intervention Results
Radic et al 2014
Acute or subacute SDH
LEV 1g IV load then 500-1000 mg IV/PO BID PHT 15-20 mg/kg IV load followed by 15-20 mg/g/day IV/PO divided TID
• N=284 (124 PHT, 164 LEV) • No significant difference in
clinical and/or electrographic seizure risk
• Decreased risk of adverse events in LEV arm (p<0.001)
Won et al 2017
Acute SDH No intervention (Comparison of seizure and antiseizure groups)
• N=139 • Overall incidence of seizures
was 38% • Independent predictors of
seizures: • GCS < 9 • Operation after 24 hrs • Anticoagulation
Radic JA, Chou SH, Du R, Lee JW. Neurocrit Care. 2014;21(2):228-37. Won SY, Dubinski D, Herrmann E, et al. World Neurosurg. 2017;101:416-424.
![Page 34: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/34.jpg)
+
Patient Case 5
![Page 35: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/35.jpg)
+Patient Case 5
n CH is a 37 year-old M admitted to the ED after sustaining a traumatic subdural hematoma
n On admission, his GCS score falls from 10 to 7 over 10 minutes and his nurse notices facial twitching
Current Medications
Fosphenytoin 200 mg PE IV q12h
Famotidine 20 mg IV q12h
Heparin 5000 units SC q8h
Docusate 250 mg NG BID
Cook A, Brophy G. Critical Care Pharmacy Preparatory Review Course. 2015;(2):51-93.
![Page 36: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/36.jpg)
+
Status Epilepticus Management
![Page 37: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/37.jpg)
+SE Treatment
• Benzodiazepine preferred
• Diazepam 0.15-0.2 mg/kg/dose IV
• Lorazepam 0.1 mg/kg IV (max 4 mg/dose)
• Midazolam 5-10 mg IM
Emergent
• Initiate antiepileptic • Fosphenytoin 18-20 mg/kg
IV • Levetiracetam 60 mg/kg IV • Phenobarbital 20 mg/kg IV • Valproate 20-40 mg/kg IV
Urgent • Repeat urgent therapy or use additional urgent therapy
• Lacosamide 200-400 mg IV
• Midazolam 0.5-2 mg/kg/hr infusion
• Pentobarbital 25 mg/kg load then 1-5 mg/kg/hr infusion
• Propofol 20 mcg/kg/min
Refractory
Brophy GM, Bell R, Claassen J, et al. Neurocrit Care. 2012;17(1):3-23. Glauser T, Shinnar S, Gloss D, et al. Epilepsy Curr. 2016;16(1):48-61.
![Page 38: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/38.jpg)
+IV Lorazepam vs IM Midazolam: Results
Silbergleit R, Durkalski V, Lowenstein D, et al. N Engl J Med. 2012;366(7):591-600.
![Page 39: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/39.jpg)
+SE Second Line Management Title Population Intervention Results
Agarwal et al 2007
Benzodiazepine refractory patients with SE
• VA 20 mg/kg IV load or
• PHT 20 mg/kg IV
• N=100 (50 VA, 50 PHT) • IV VA was successful in
88% and IV PHT in 84% (p>0.05) of SE patients
• Total number of adverse events did not differ significantly between the two groups (p>0.05)
Alvarez et al 2011
Benzodiazepine refractory patients with SE
• VA 20 mg/kg IV load followed by 1000-2500 mg
• PHT 20 mg/kg IV load followed by 300-400 mg
• LEV 20 mg/kg IV load followed by 1000-3000 mg
• N=167 (198 SE episodes: 70 PHT, 59 VA, 58 LEV)
• LEV failed to control SE in 48.3%, PHT in 41.4%, VA in 25.4%
• LEV was related to a higher risk of second-line treatment failure compared to VA (OR 2.7 [1.2,6.1])
Agarwal P, Kumar N, Chandra R, Gupta G, et al. Seizure. 2007;16(6):527-32. Alvarez V, Januel JM, Burnand B, Rossetti AO. Epilepsia. 2011;52(7):1292-6.
![Page 40: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/40.jpg)
+Refractory SE Management Title Population Intervention Results
Prasad et al 2001
Refractory SE patients
• Propofol (PROP) 1-3 mg/kg bolus, 1-10 mg/kg/hr infusion
• Midazolam (MDL) 2-12 mg bolus, 0.05-0.8 mg/kg/hr infusion
• N=20 (14 PROP, 6, MDL) • PROP and MDL therapy achieved
64 and 67% complete clinical seizure suppression and 78 and 67% electrographic seizure suppression, respectively
Claassen et al 2002
Refractory SE patients
• PROP, MDL, or pentobarbital (PTB)
• N=193 (54 MDL, 33 PROP, 106 PTB) • Mortality was not associated with
choice of agent or titration goal • PTB treatment was associated with
a lower frequency of short-term treatment failure (p<0.01), breakthrough seizures but had a higher frequency of hypotension (p<0.001)
Prasad A, Worrall BB, Bertram EH, Bleck TP. Epilepsia. 2001;42(3):380-6. Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Epilepsia. 2002;43(2):146-53.
![Page 41: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/41.jpg)
+Summary: SE Medications
Medication Dosing Adverse Effect Lorazepam 0.1 mg/kg IV (max 4 mg/dose up to 8 mg
total) Sedation, hypotension
Midazolam 0.2 mg/kg IM (max dose 10 mg) Sedation, hypotension
Diazepam 0.15-0.20 mg/kg IV (max 10 mg/dose, may repeat dose once)
Sedation, hypotension
Fosphenytoin 18-20 mg PE/kg IV (max dose 1500 mg PE/dose, max rate 150 mg PE/min)
Hypotension, arrhythmia
Phenytoin 18-20 mg/kg IV (max rate 50 mg PE/min)
Hypotension, arrhythmia, phlebitis, purple glove syndrome
Valproic acid 20-40 mg/kg IV (max 3000 mg/dose, max rate 6 mg/kg/min)
Hyperammonemia
Levetiracetam 60 mg/kg (max 4500 mg/dose, max rate 5 mg/kg/min)
Sedation, irritability
Lacosamide 200-400 mg IV (over 15-30 min) Dizziness, bradyarrhythmia
Brophy GM, Bell R, Claassen J, et al. Neurocrit Care. 2012;17(1):3-23. Glauser T, Shinnar S, Gloss D, et al. Epilepsy Curr. 2016;16(1):48-61.
![Page 42: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/42.jpg)
+Summary: SE Medications
Medication Dosing Adverse Effect
Topiramate Load of 500 mg PO BID x 2 days, taper to 200 mg BID by 200 mg/day every 2 days
Metabolic acidosis
Phenobarbital 20 mg/kg IV (max rate 100 mg/min)
Sedation, hypotension, respiratory depression
Pentobarbital 10 mg/kg IV Sedation, hypotension, respiratory depression
Midazolam high-dose infusion
0.05-2 mg/kg/hr IV Sedation, hypotension, respiratory depression
Propofol 20-200 mcg/kg/min IV , titrate by 5 mcg/kg/min
Sedation, hypotension, PRIS
Brophy GM, Bell R, Claassen J, et al. Neurocrit Care. 2012;17(1):3-23. Glauser T, Shinnar S, Gloss D, et al. Epilepsy Curr. 2016;16(1):48-61.
![Page 43: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/43.jpg)
+Summary: TBI and Brain Bleeds
TBI • ✓Seizure prophylaxis: phenytoin or levetiracetam • Avoid valproate and phenobarbital
ICH • ✗ No seizure prophylaxis due to increased mortality
SAH • ? Depends on risk • Consider phenytoin or levetiracetam
SDH • ✓Phenytoin, levetiracetam preferred (similar to TBI)
![Page 44: Shake It Up: Seizure Prophylaxis and Status - Damon's Due · 2018-01-06 · TBI Related Seizures n Seizure onset n Early 0 - 7 days n Late > 7 days n Risk factors for seizure development](https://reader034.fdocuments.us/reader034/viewer/2022042309/5ed58d73e4e9005a3e7b084a/html5/thumbnails/44.jpg)
+
Shake It Up: Seizure Prophylaxis and Status Epilepticus Management
Emily Yarborough, PharmD PGY2 Critical Care Pharmacy Resident January 4, 2018